Baker Bros. Advisors’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Baker Bros. Advisors’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-119,200	Closed	-$5.23M	–	130
2021 Q2	$5.23M	Buy	119,200 +45,757	+62%	+$2.55M	0.02%	96
2021 Q1	$5.33M	Buy	73,443 +40,193	+121%	+$2.85M	0.02%	91
2020 Q4	$1.44M	Sell	33,250 -1,070	-3%	-$47.9K	0.01%	112
2020 Q3	$1.41M	Sell	34,320 -6,250	-15%	-$323K	0.01%	108
2020 Q2	$2.43M	Hold	40,570	–	–	0.01%	98
2020 Q1	$3.06M	Hold	40,570	–	–	0.02%	79
2019 Q4	$5.58M	Hold	40,570	–	–	0.03%	68
2019 Q3	$4.82M	Hold	40,570	–	–	0.03%	64
2019 Q2	$5.68M	Buy	40,570 +28,070	+225%	+$4.93M	0.04%	62
2019 Q1	$2.23M	Hold	12,500	–	–	0.01%	77
2018 Q4	$1.97M	Buy	+12,500	New	+$1.86M	0.02%	74

Other funds holding ORTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Baker Bros. Advisors's ORTX Position: Q3 2021 in Review

Baker Bros. Advisors sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2021, closing a stake of 119,200 shares — an estimated $5.23M sold.

Baker Bros. Advisors first reported a position in ORTX in Q4 2018 and held it in 11 quarters. The position peaked at $5.68M in Q2 2019. 79 funds tracked by Wall St. Rank hold ORTX as of Q3 2021.

Baker Bros. Advisors reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2021 after selling out during the quarter.
Baker Bros. Advisors sold 119,200 Orchard Therapeutics plc American Depositary Shares shares in Q3 2021, an estimated $5.23M.
Baker Bros. Advisors first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 11 quarters.
Baker Bros. Advisors's Orchard Therapeutics plc American Depositary Shares position peaked at $5.68M in Q2 2019.
79 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2021.

Based on Baker Bros. Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.